Skip to Main Content

James Huie

Partner, Capital Markets

jameshuie@paulhastings.com
San Francisco+1 415 856 7260

James Huie is a San Francisco-based partner in the Capital Markets practice at Paul Hastings.

James advises life sciences and technology companies on general corporate matters, mergers and acquisitions, initial public offerings, strategic partnerships, and private equity and debt financings. He also has extensive experience representing venture capital firms and other investors in private equity and debt financings.

His practice focuses on advising early and late-stage start-ups throughout all stages of their lifecycle, along with numerous venture investors. His clients comprise the full range of the start-up ecosystem, from one-person companies to unicorns preparing for public offerings.

EDUCATION

Santa Clara University, School of Law, J.D., 2005

University of California, Berkeley, B.A., 2002

REPRESENTATIONS

Representations Teest
  • Umoja Biopharma in its $210 million Series B financing led by Softbank Vision Fund and Cormorant Asset Management.

  • Noah Medical in its $150 million Series B financing led by Softbank Vision Fund and Prosperity7 Ventures.

PUBLICATIONS

  • “FoodTech White Paper: 2020 Trends in Venture Capital Financings,” Author

    March 2021